Published retrospective analysis of failed clinical trials that have utilised Convection-Enhanced Delivery (CED) as the infusion mechanism have highlighted that a small number of system elements (targeting, device design, lack of real-time imaging etc.) can cause poor outcomes and prevent primary trial objectives being met. A limited number of systems exist for acute, stereotactically guided delivery but systems and strategies for longer term applications are lacking. The problem of achieving controlled intermittent delivery to the brain must therefore be tackled at the system level. Through a collaborative relationship between research and industry it has been possible to bring together multidisciplinary teams and implement a lab to clinic development paradigm. Engineering developments in surgical planning software, rigid tooling and surgical robotics have laid a solid foundation on which to improve surgical techniques, implant design and external re-access kits. Investigation of a guide tube catheter assembly was conducted first in the Agarose gel model and later in the porcine and canine model to help inform surgical planning strategies. Catheter design features were manipulated as a variable to induce changes in the infusion morphology and were investigated over time. Methods for ongoing distribution optimisation were also reviewed. Acquisition of anatomical targets ∼120mm deep can now be achieved sub millimetre utilising the surgical system. Greater coverage of anatomical structures is possible through device modifications which effect changes to the infusion morphology. Ongoing optimisation of infusions might be achieved through periodic imaging and implementing improved, patient specific infusion regimes. A multidisciplinary approach to the problem of chronic implantation is required to achieve successful intermittent infusions in the brain.
. 2015 Nov 9;17(Suppl 5):v75–v76. doi: 10.1093/neuonc/nov212.12
DDEL-12: A SYSTEM BASED APPROACH TO CHRONIC DRUG DELIVERY - A METHOD THAT WORKS
Owen Lewis
1,3, Max Woolley
1, Dave Johnson
1, Neil Barua
2, Paul Skinner
1, Charlie Irving
1, Suk Kinch
1, Mike Howell
1, Grace Stewart
1, Gemma Pritchard
1, Patrick Moore
1, Julia Fletcher
1, Alison Bienemann
2, Sam Evans
3, Anne Rosser
4, Steven Gill
1,2
Owen Lewis
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
3School of Engineering, Cardiff University, The Parade, Cardiff, UK
Find articles by Owen Lewis
Max Woolley
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
Find articles by Max Woolley
Dave Johnson
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
Find articles by Dave Johnson
Neil Barua
2Functional Neurosurgery Research Group, University of Bristol, Southmead hospital, Bristol, UK
Find articles by Neil Barua
Paul Skinner
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
Find articles by Paul Skinner
Charlie Irving
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
Find articles by Charlie Irving
Suk Kinch
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
Find articles by Suk Kinch
Mike Howell
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
Find articles by Mike Howell
Grace Stewart
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
Find articles by Grace Stewart
Gemma Pritchard
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
Find articles by Gemma Pritchard
Patrick Moore
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
Find articles by Patrick Moore
Julia Fletcher
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
Find articles by Julia Fletcher
Alison Bienemann
2Functional Neurosurgery Research Group, University of Bristol, Southmead hospital, Bristol, UK
Find articles by Alison Bienemann
Sam Evans
3School of Engineering, Cardiff University, The Parade, Cardiff, UK
Find articles by Sam Evans
Anne Rosser
4School of Biosciences, Cardiff University, Sir Martin Evans Building, Cardiff, UK
Find articles by Anne Rosser
Steven Gill
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
2Functional Neurosurgery Research Group, University of Bristol, Southmead hospital, Bristol, UK
Find articles by Steven Gill
1Neurological Applications Department, Renishaw PLC, Wotton-Under-Edge, Gloucestershire, UK
2Functional Neurosurgery Research Group, University of Bristol, Southmead hospital, Bristol, UK
3School of Engineering, Cardiff University, The Parade, Cardiff, UK
4School of Biosciences, Cardiff University, Sir Martin Evans Building, Cardiff, UK
Issue date 2015 Nov.
Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2015.
PMCID: PMC4638733
